Stem Cells: Review and Update

Archives of Surgery

Volumn 139, Issue 1, 2004, Pages 93-99

  Sylvester, Karl G ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CELL CLONING; CELL REGENERATION; PRIORITY JOURNAL; REVIEW; STEM CELL; SURGEON; TISSUE REGENERATION;

ANIMALS; ETHICS, MEDICAL; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MICE; REGENERATION; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TRANSPLANTATION CONDITIONING; UNITED STATES;

EID: 0346998062     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.139.1.93     Document Type: Review

References (97)

1. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385:810-813.
2. Bianco P, Robey PG. Stem cells in tissue engineering. Nature. 2001;414:118-121.
3. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl. 2002;38:73-79.
4. Lovell-Badge R. The future for stem cell research. Nature. 2001;414:88-91.
5. Surani MA. Reprogramming of genome function through epigenetic inheritance. Nature. 2001;414:122-128.
6. Weissman IL. Stem cells: scientific, medical, and political issues. N Engl J Med. 2002;346:1576-1579.
7. McLaren A. Ethical and social considerations of stem cell research. Nature. 2001;414:129-131.
8. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature. 2001;414:92-97.
9. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature. 2001;414:98-104.
10. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
11. Lanza RP, Cibelli JB, Faber D, et al. Cloned cattle can be healthy and normal. Science. 2001;294:1893-1894.
12. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154-156.
13. Lanza RP, Chung HY, Yoo JJ, et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol. 2002;20:689-696.
14. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99:9864-9869.
15. Cibelli JB, Campbell KH, Seidel GE, West MD, Lanza RP. The health profile of cloned animals. Nat Biotechnol. 2002;20:13-14.
16. Rideout WM III, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 2002;109:17-27.
17. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245-254.
18. Humpherys D, Eggan K, Akutsu H, et al. Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad Sci U S A. 2002;99:12889-12894.
19. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro [published correction appears in Nat Biotechnol. 2000;18:559]. Nat Biotechnol. 2000;18:399-404.
20. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro [published correction appears in Nat Biotechnol. 2000;18:559]. Nat Biotechnol. 2000;18:399-404.
21. Billon N, Jolicoeur C, Ying QL, Smith A, Raff M. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cell Sci. 2002;115:3657-3665.
22. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest. 1996;98:216-224.
23. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99:4391-4396.
24. Murray P, Edgar D. The regulation of embryonic stem cell differentiation by leukaemia inhibitory factor (LIF). Differentiation. 2001;68:227-234.
25. Roach ML, McNeish JD. Methods for the isolation and maintenance of murine embryonic stem cells. Methods Mol Biol. 2002;185:1-16.
26. Tremain N, Korkko J, Ibberson D, Kopen GC, DiGirolamo C, Phinney DG. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells. 2001;19:408-418.
27. Terskikh AV, Easterday MC, Li L, et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci U S A. 2001;98:7934-7939.
28. Bortvin A, Eggan K, Skaletsky H, et al. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development. 2003;130:1673-1680.
29. The White House Web site. Remarks by the President on stem cell research. August 9, 2001. Available at: http://www.whitehouse.gov/news/releases/2001/08 /print/20010809-2.html. Accessed October 27, 2003.
30. National Institutes of Health Web site. Stem Cell Information. Bethesda, Md: National Institutes of Health; 2002. Available at http://stemcells.nih.gov/index.asp. Accessed October 27, 3002.
31. Dickson D. New regulations give UK the lead in stem cell work [news]. Nat Med. 2002;8:315.
32. Birmingham K. Stem cell scientist moves to Singapore [news]. Nat Med. 2002;8:314.
33. Dennis C. Compromise for Australian ES cell research [news]. Nat Med. 2002;8:430.
34. Cimons M. Bush policy: attention turns to existing human ES cells. Nat Med. 2001;7:981-982.
35. Committee on the Biological and Biomedical Applications of Stem Cell Research. Stem Cells and the Future of Regenerative Medicine. Washington, DC: National Academy Press; 2002.
36. Panel on Scientific and Medical Aspects of Human Reproductive Cloning. Scientific and Medical Aspects of Human Reproductive Cloning. Washington, DC: National Academy Press; 2002.
37. Grady D, Pear R. Claim of human cloning provokes harsh criticism: many fear backlash on stem cell research. New York Times. December 29, 2002:18.
38. Blanco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001;19:180-192.
39. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.
40. Weisman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17:387-403.
41. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157-168.
42. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-1530.
43. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000;290:1775-1779.
44. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-1234.
45. Hirschi KK, Goodell MA. Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells. Gene Ther. 2002;9:648-652.
46. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-1402.
47. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000;32:11-16.
48. Kleeberger W, Rothamel T, Glockner S, Flemming P, Lehmann U, Kreipe H. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology. 2002;35:110-116.
49. Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci U S A. 2003;100:2088-2093.
50. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346:5-15.
51. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 2001;105:829-841.
52. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med. 2001;7:393-395.
53. Goodell MA, Jackson KA, Majka SM, et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci. 2001;938:208-218; discussion, 218-220.
54. Krause DS. Plasticity of marrow-derived stem cells. Gene Ther. 2002;9:754-758.
55. Wulf GG, Jackson KA, Goodell MA. Somatic stem cell plasticity: current evidence and emerging concepts. Exp Hematol. 2001;29:1361-1370.
56. Krause DS, Theise NO, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369-377.
57. Krause DS. BM-derived stem cells for the treatment of nonhematopoietic diseases. Cytotherapy. 2002;4:503-506.
58. Theise ND, Krause DS, Sharkis S. Comment on "Little evidence for developmental plasticity of adult hematopoietic stem cells." Science. 2003;299:1317.
59. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297:2256-2259.
60. Cousin B, Andre M, Arnaud E, Penicaud L, Casteilla L. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun. 2003;301:1016-1022.
61. Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells. 2002;20:11-20.
62. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545.
63. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 2002;416:545-548.
64. Devine SM, Peter S, Martin BJ, Barry F, McIntosh KR. Mesenchymal stem cells: stealth and suppression. Cancer J. 2001;7(suppl 2):S76-S82.
65. Gerson SL. Mesenchymal stem cells: no longer second class marrow citizens [comment]. Nat Med. 1999;5:262-264.
66. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
67. Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000;97:3213-3218.
68. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A. 2001;98:7841-7845.
69. Deng W, Obrocka M, Fischer I, Prockop DJ. In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun. 2001;282:148-152.
70. Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood. 1994;84:4164-4173.
71. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood. 1995;85:929-940.
72. Guo Z, Yang J, Liu X, et al. Biological features of mesenchymal stem cells from human bone marrow. Chin Med J (Engl). 2001;114:950-953.
73. Horwitz EM, Keating A. Nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy. 2000;2:387-388.
74. Jalswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64:295-312.
75. Pereira RF, O'Hara MD, Laptev AV, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A. 1998;95:1142-1147.
76. Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem Suppl. 2002;38:7-12.
77. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci. 2001;938:231-233; discussion, 233-235.
78. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A. 2002;99:4397-4402.
79. Simmons PJ, Gronthos S, Zannettino A, Ohta S, Graves S. Isolation, characterization and functional activity of human marrow stromal progenitors in hemopoiesis. Prog Clin Biol Res. 1994;389:271-280.
80. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
81. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002;30:896-904.
82. Holden C, Vogel G. Stem cells: plasticity: time for a reappraisal? Science. 2002;296:2126-2129.
83. Vogel G. Cell biology: stem cells: new excitement, persistent questions. Science. 2000;290:1672-1674.
84. Bianco P, Robey PG. Marrow stromal cells. J Clin Invest. 2000;105:1663-1668.
85. Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol. 2002;3:323-328.
86. Weissman IL, Baltimore D. Disappearing stem cells, disappearing science [editorial]. Science. 2001;292:601.
87. Bordignon C, Roncarolo MG. Therapeutic applications for hematopoietic stem cell gene transfer. Nat Immunol. 2002;3:318-321.
88. Ballas CB, Zielske SP, Gerson SL. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl. 2002;38:20-28.
89. Lemoine NR. The power to deliver: stem cells in gene therapy. Gene Ther. 2002;9:603-605.
90. Lagasse E, Shizuru JA, Uchida N, Tsukamoto A, Weissman IL. Toward regenerative medicine. Immunity. 2001;14:425-436.
91. Park KI, Ourednik J, Ourednik V, et al. Global gene and cell replacement strategies via stem cells. Gene Ther. 2002;9:613-624.
92. Eiselt P, Kim BS, Chacko B, et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog. 1998;14:134-140.
93. Kim WS, Vacanti CA, Upton J, Vacanti JP. Bone defect repair with tissue-engineered cartilage. Plast Reconstr Surg. 1994;94:580-584.
94. Pereira RF, Halford KW, O'Hara MD, et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995;92:4857-4861.
95. Horwitz EM, Prockop DJ, Gordon PL, et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood. 2001;97:1227-1231.
96. Kaufman CL, Ildstad ST. Induction of donor-specific tolerance by transplantation of bone marrow. Ther Immunol. 1994;1:101-111.
97. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168-170.